Ellevest, Inc.
Source: SEC Form 13F · as of Mar 2026Ellevest, Inc. holds 25 biotech & pharma companies tracked by BioSniper, totaling $24.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$24.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 3,274 | $3.0M |
| MRKMerck & Co., Inc. | 23,577 | $2.8M |
| NVSNovartis AG | 11,912 | $1.8M |
| JNJJOHNSON & JOHNSON | 7,155 | $1.7M |
| PFEPFIZER INC | 43,044 | $1.2M |
| AZNASTRAZENECA PLC | 5,758 | $1.1M |
| GILDGILEAD SCIENCES, INC. | 7,097 | $989K |
| MCKMcKesson Corporation | 1,112 | $962K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 17,417 | $961K |
| AMGNAMGEN INC | 2,730 | $961K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,349 | $906K |
| IDXXIDEXX LABORATORIES INC /DE | 1,460 | $820K |
| ABTABBOTT LABORATORIES | 7,962 | $817K |
| BIIBBIOGEN INC. | 3,946 | $723K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,442 | $644K |
| SNYSanofi | 12,791 | $616K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,837 | $608K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 29,411 | $545K |
| ABBVAbbVie Inc. | 2,479 | $539K |
| BMYBRISTOL MYERS SQUIBB CO | 8,501 | $516K |
| REGNREGENERON PHARMACEUTICALS, INC. | 631 | $488K |
| ARGXARGENX SE | 472 | $345K |
| INSMINSMED Inc | 1,966 | $321K |
| ELVElevance Health Inc. | 1,079 | $316K |
| CAHCardinal Health Inc. | 1,009 | $213K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.